S. Urano

IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.

K. Akagawa, T. Nei, K. Nakata, 2012, American journal of physiology. Lung cellular and molecular physiology.

Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.

Y. Nasuhara, Y. Inoue, M. Ebina, 2012, Respiratory medicine.

Aphidicolin-resistant mutants of bacteriophage phi 29: genetic evidence for altered DNA polymerase.

K. Matsumoto, H. Hirokawa, M. Ohashi, 1986, Virology.

Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis

Y. Nasuhara, Y. Inoue, M. Ebina, 2012, European Respiratory Journal.

PKC-Mediated ZYG1 Phosphorylation Induces Fusion of Myoblasts as well as of Dictyostelium Cells

Y. Maeda, T. Isono, M. Omatsu-Kanbe, 2012, International journal of cell biology.

Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects.

N. Kitamura, T. Nei, K. Nakata, 2019, Immunology letters.

Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.

N. Kitamura, Y. Inoue, T. Nei, 2013, Clinical immunology.

Electromagnetic interference on medical equipment by low-power mobile telecommunication systems

Kazuhiko Ohe, Yoshiaki Nose, Yasuaki Antoku, 2000 .

A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies.

M. Tomita, T. Nei, K. Nakata, 2010, Journal of immunological methods.